Melanoma
News
Cancer Diagnosis Appears to Raise Suicide, Cardiovascular Risks
Major Finding: The rate of completed suicide was twice as high among adults with newly diagnosed cancer of any kind (0.36 per 1,000 person-years)...
News
Limb Perfusion for In-Transit Melanoma Reduces Distant Recurrences
Major Finding: Hyperthermic isolated limb perfusion was significantly better than isolated limb infusion at preventing out-of-field, in-transit...
News
Melanoma on Scalp Signals Worse Prognosis Than Other Sites
Major Finding: Compared with melanomas originating at other body sites, scalp melanomas are associated with worse 5-year melanoma-specific...
News
Extramammary Paget's Needs More Than Mohs
News
Bexarotene Confers No Survival Benefit for Mycosis Fungoides
Major Finding: The median survival time for patients with tumor stage mycosis fungoides who received oral bexarotene therapy was 3.3 years,...
News
Sunburns Still Common Despite Protective Efforts
Major Findings: In 2010, 51% of women and 49% of men reported having at least one sunburn in the past year.
Conference Coverage
Off-Label Use of Aprepitant Quells Refractory Pruritus
Article
Vemurafenib in melanoma with the BRAF V600E mutation
News
'Early, Proactive' Management of Chemo Toxicites Improves QOL
News
VEGF-Targeting Cancer Drugs Raise Risk of Fatal Side Effects
News
New Vemurafenib Data Highlight Long-Term Melanoma Survival
Major Finding: The overall response rate to vemurafenib was 53%, and median overall survival was 16 months.Data Source: The multicenter phase II...